AzTrials
AzTrials

Chronic PeriodontitisNCT03039244

Evaluation of Antimicrobial Photodynamic Therapy as an Adjunct to Periodontal Treatment in Smokers

A study testing Photodynamic therapy and Diode Laser in people with Chronic Periodontitis, run by University of Sao Paulo at 1 site in Brazil.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The study proposes to assess the effect of multiple applications of antimicrobial Photodynamic Therapy (aPDT) as an adjunct to non-surgical periodontal treatment (nsPT) in smokers without use of antibiotics. Read more about this study

Who is it for?
Ages 30 to 60 yearsHealthy volunteers can take part
Conditions the study is for
Chronic Periodontitis
What is being tested?
Photodynamic therapy and Diode Laser
Type of treatment
Medical device
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
20 participants
Where
1 siteBrazil
Study dates
1 Sep 2014to 1 Sep 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 30 to 60 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • diagnosis of chronic periodontitis according to the international classification of periodontal diseases adopted by the American Academy of Periodontology (Armitage, 1999)
  • periodontal pockets ≥ 5 mm
  • smoking ≥ 20 cigarettes per day

Who cannot join

  • Positive history of antibiotic therapy in the last six months
  • Positive history of basic periodontal treatment in the last six months
  • Involvement systemic that might interfere in disease progression or treatment response (eg .: diabetes, immune disorders)
  • Pregnant
  • Patients with extensive prosthetic wrap
  • Patients with the need for antibiotic prophylaxis for performing routine dental procedures

Trial locations and contacts

1 site in 1 country.

Brazil1 site
  • Mariana Sales

    Ribeirão Preto, São Paulo, 14025710

Other trials in Brazil

About this study

Official title: Evaluation of Antimicrobial Photodynamic Therapy in Multiples Episodes as an Adjunct to Non-surgical Periodontal Treatment in Smokers

The study proposes to assess the effect of multiple applications of antimicrobial Photodynamic Therapy (aPDT) as an adjunct to non-surgical periodontal treatment (nsPT) in smokers without use of antibiotics. Twenty smokers with a clinical diagnosis of chronic periodontitis will be treated in a split-mouth design study to either aPDT associated with scaling and root planing (SRP) or SRP only. aPDT will be performed by using a laser light source with 690 nm wavelength associated with a phenothiazine photosensitizer. The applications will occur in four episodes (at days 0, 2, 7 and 14). All patients will be monitored for 90 days. Plaque index, probing depth, clinical attachment level and bleeding on probing will be performed at baseline (pre-intervention period) and 30 and 90 days after the (nsPT). Subgingival plaque samples will be collected (at baseline and 30 and 90 days after the nsPT) and the counts of 40 subgingival species will be determined using DNA-DNA checkerboard hybridization. Gingival crevicular fluid samples will be collected (at Day 0, 14, 30 and 90 after the nsPT) and the levels of Interleukin 1 beta, Interleukin 10 and Tumor Necrosis Factor alpha (Luminex) will be evaluated. Salivary cotinine levels will also be evaluated at baseline. Data obtained will be statistically analyzed.

Read the detailed description

MATERIALS AND METHODS

Consent to search - All patients will receive detailed information about experiment (goals, benefits, risks and discomforts) in accordance with a consent form in this research. All procedures will be subject to approval of the Ethics Committee (CEP) of Ribeirão Preto Dental School (FORP), University of São Paulo (USP).

Sample Size Calculation - The sample size was determined to provide 80% power to recognize a significant difference of 1 mm (d) between groups with a 95% confidence interval (a = 0.05) and standard deviation (s) of 1.0 mm. Considering the changes in mean clinical attachment level (CAL) as the primary outcome variable and [Za (1.96) + Zb (0.84)]2 = 7.84. Size calculation was based on the following formula: n = {2[(s)2/(d)2]} · (Za + Zb)2. Therefore, a total of 16 patients were required. However, the number of patients enrolled in this study was 20, considering that some patients could be lost during follow-up.

Experimental Design -The selected subjects will receive specific oral hygiene instruction and supragingival scaling in all teeth, seven days before the start of interventions. The study type will be split mouth with two pairs of contralateral uni-root teeth with proximal periodontal sites presenting probing depth ≥ 5 mm for the clinical, microbiological and immunological assessment. A random number table will be generated by a computer program, each of the selected pairs dental receive the following treatments: SRP or SRP + several aPDT episodes. The clinical, immunological and microbiological parameters will be evaluated at baseline (pre-intervention) and after the completion of non-surgical periodontal therapy. The periodontal clinical examinations (pre and post-intervention) will be performed by a single trained and calibrated examiner, who unknown the experimental groups of this study. Examiners are also blind to study the immunological and microbiological analyzes. SRP procedures and use of the aPDT protocol should be performed by other trained operator for these purposes.

An impression with alginate will be performed in each patient to obtain the models of the dental arches and development of a guide plate on acetate with reference grooves to standardize the insertion and inclination of computerized periodontal probe (Florida Probe System, Florida Probe Corporation , Gainesville, FL, USA). The visible plaque index of each patient, will be assessed dichotomously (O'Leary et al., 1972) and determined by the percentage of tooth surfaces with plaque. In 6 sites of each tooth (mesio-buccal, buccal, distobuccal, mesio- lingual, lingual and disto-lingual) will be assessed clinical periodontal parameters: Probing Depth (mm) that will be measured from the gingival margin to the pocket bottom; relative Clinical Attachment Level (mm) that will be measured from the occlusal plate guide to the pocket bottom; Bleeding on probing, rated dichotomously (Ainamo, Bay, 1976), the presence of bleeding is considered positive when presented within 20s after the probe insertion for measuring probing depth. These clinical parameters and each patient's plaque index will be recorded at baseline (pre-intervention period) as well as +30 and +90 days after the non-surgical periodontal therapy.

Examiner Calibration - The Kappa index will be used to evaluate the examiner calibration for collection of clinical periodontal parameters in order to measure the intra-examiner agreement. According to the World Health Organization (WHO) for diagnostic criteria, acceptable index Kappa agreement must be greater or equal to 0.85 (WHO, 1997). This agreement level will be used for calibration of the examiner in this project. Ten patients will be selected, at least two pairs of contralateral teeth uni-roots with probe depth ≥5 mm in the proximal sites. Each patient is scanned twice using computerized periodontal probe (Probe Corporation Florida, Gainesville, FL, USA) with a 48-hour interval between the first and second examination in order to obtain the intra-examiner reliability, which will be measured by determining the Kappa index.

Immunologic Analysis - At baseline and on days +14, +30 and +90, after non-surgical periodontal therapy will be collected GCF samples from selected teeth. The supragingival plaque these elements will be removed and the sites will be gently dried with air jets and subsequently isolated using sterile cotton rolls. The GCF samples are obtained from the mesial and distal sites to the use of Periopaper strips (Oralflow Inc., Amityville, NY, USA). The strips will be carefully placed on the margin of the gingival sulcus for 30 seconds. The amount of absorbed gingival fluid will be determined by an electronic meter of wet mass Periotron (Oralflow Inc., Amityville, NY). The strips are placed in sterile eppendorf vials of the type which will be stored at a temperature of 80C for later quantification of cytokines (pg/ml) TNF-α, IL-1β and IL-10. Cytokine levels are determined using a 3-plex kit Millipore (Millipore Corporation, Billerica, MA, USA) 100TM and the Luminex system (Luminex, MiraiBio, Alameda, CA, USA).

Salivary Cotinine analysis - Cotinine is a metabolite of nicotine which allows monitoring patient exposure to nicotine (McGuire et al., 1989). Cotinine levels will be identified at baseline by immunoenzymatic analysis (ELISA) (Salimetrics Inc., State College, PA, USA) using a kit for the quantitative analysis of cotinine in saliva according to the manufacturer's instructions.

Microbiological Analysis - At baseline and on days +30 and +90, after performing non-surgical periodontal therapy, subgingival plaque samples of the selected teeth will be collected at the proximal periodontal pockets (mesial and distal). Counts of 40 subgingival species will be determined in each sample using the method checkerboard DNA-DNA hybridization (Birth et al., 2008). For the collection of subgingival plaque, the sites will be isolated with sterile cotton rollers and dry with air jets. The supragingival plaque will be removed carefully using a sterile curette. Subsequently, another sterile curette is used to collect subgingival plaque, starting from the deepest portion of the pocket to the coronal region. The samples will be transported in sterile Eppendorf vials and processing in Dental Molecular Diagnostics Laboratory of the School of Dentistry of Ribeirão Preto-USP

Non-surgical Periodontal Therapy - At 7 day prior to the non-surgical periodontal therapy all patients will pefrom a complete periapical radiographic examination of the entire mouth. They will be grouped into an oral hygiene program (OHP) according to the specific needs. In this program patients will receive instructions for effective self-plaque, including information about Bass technique (Bass, 1954) and interproximal cleaning with dental floss and interdental brushes. They will also be encouraged to brush the tongue once a day and receive a single dentifrice to be used during the whole experimental period (Colgate Total, Anakol Ind. Com. Ltda - Kolynos do Brasil - Colgate Palmolive Co., São Bernardo do Campo, SP, Brasil). After the completion of this oral hygiene program, patients will be submitted to evaluation of clinical periodontal parameters previously described, and also will be collected subgingival plaque and GCF samples on selected sites (baseline - pre-intervention period). Soon after, will receiving supragingival scaling and polishing with a coronary rubber cups in all teeth in the oral cavity.

Non-surgical periodontal therapy is initiated 7 days after the execution of the OHP and initial supragingival scaling. The treatment will be made by one skilled in Periodontology, at an interval of 24 hours by scaling (supragingival and subgingival) and root planing of all teeth with periodontal disease, using hand (Curetas Gracey, Hu-Friedy, Chicago, IL, EUA) and ultrasonic tools. The instrumentation will be held quadrant by quadrant, until adequate cleaning of the area and root planing, which will be checked with the help of an explorer. Individuals will receive professional cleaning biweekly up to three months after the end of nonsurgical periodontal therapy. In Fortnightly control and evaluation, patient cooperation towards the study will be monitored, verifying the state of oral hygiene.

Statistical Analysis - Normality and homoscedasticity of the data will be checked. The inter- and intra-group comparisons in different time intervals will be achieved through adequate parametric or non-parametric tests. For all statistical analysis will use a 5% significance level. All calculations are performed using SPSS software (SPSS, Chicago IL, EUA).

Being tested
Photodynamic therapy, Control Group, Diode Laser
Keywords
Photochemotherapy, Photosensitizing agents, Smokers
Medical subject headings
Chronic Periodontitis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Photodynamic therapyOther

    Also called Laser therapy

    After Scaling and root planing, periodontal pockets will receive the antimicrobial (aPDT) photodynamic therapy. Shortly phenothiazine hydrochloride photosensitizing is applied at a concentration of 10mg/mL from the pocket bottom to the gingival margin. After 1 minute, irrigation is performed from periodontal pockets with distilled water to remove excess dye. The stained area is then irradiated with a diode laser with 660 nm of wavelength and maximum power of 60 mW/cm², through a fiber-optic probe of 0.6 mm diameter. Exposure to radiation will occur at six sites per tooth under treatment, making the total time of 1 minute per element, or the equivalent of 10 seconds per site. The aPDT applications will be repeated in the same way until the second week in the days 2, 7 and 14.

  • Control GroupOther

    Also called Sham procedure

    A sham procedure will be held simultaneously in pairs of contralateral teeth selected that will not receive the aPDT (control group).

  • Diode LaserDevice

Study groups in NCT03039244
Study groupRoleWhat they receive
Test GroupExperimentalAfter Scaling and root planing, periodontal pockets will receive the antimicrobial (aPDT) photodynamic therapy. Shortly phenothiazine hydrochloride photosensitizing is applied at a concentration of 10mg/mL from the pocket bottom to the gingival margin. After 1 minute, irrigation is performed from periodontal pockets with distilled water to remove excess dye. The stained area is then irradiated with a diode laser with 660 nm of wavelength and maximum power of 60 mW/cm², through a fiber-optic probe of 0.6 mm diameter. Exposure to radiation will occur at six sites per tooth under treatment, making the total time of 1 minute per element, or the equivalent of 10 seconds per site. The aPDT applications will be repeated in the same way until the second week in the days 2, 7 and 14.
Receives: Other: Photodynamic therapy; Device: Diode Laser
Control GroupSham comparatorA sham procedure will be held simultaneously in pairs of contralateral teeth selected that will not receive the aPDT (control group).
Receives: Other: Control Group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Clinical Parameter

    clinical attachment level of the selected periodontal sites

    Measured: 2 years

Secondary outcomes (4)
  1. Immunologic Analysis of the selected periodontal sites

    Cytokine levels

    Measured: 3 years

  2. Microbiological Analysis of the selected periodontal sites

    periodontal pathogens counts

    Measured: 3 years

  3. Salivary Cotinine analysis

    cotinine levels

    Measured: 3 years

  4. Clinical Parameter 2

    probing depth

    Measured: 2 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Feb 2017 (estimated)
  2. Study start1 Sep 2014
  3. Primary completion1 Dec 2016
  4. Study completion1 Sep 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Single group
Model description
The study type will be split mouth with two pairs of contralateral uni-root teeth with proximal periodontal sites presenting probing depth ≥ 5 mm for the clinical, microbiological and immunological assessment. A random number table will be generated by a computer program, each of the selected pairs dental receive the following treatments: SRP or SRP + several aPDT episodes
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03039244
Sponsor's protocol ID
36933014.4.0000.5419
Status last verified
Oct 2017
First submitted
27 Jan 2017
Last updated
26 Oct 2017
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • de Melo Soares MS, D'Almeida Borges C, de Mendonca Invernici M, Frantz FG, de Figueiredo LC, de Souza SLS, Taba M Jr, Messora MR, Novaes AB Jr. Antimicrobial photodynamic therapy as adjunct to non-surgical periodontal treatment in smokers: a randomized clinical trial. Clin Oral Investig. 2019 Aug;23(8):3173-3182. doi: 10.1007/s00784-018-2740-3. Epub 2018 Nov 3.

    PubMed 30392080

Questions about this trial

What is this clinical trial studying?

A study testing Photodynamic therapy and Diode Laser in people with Chronic Periodontitis, run by University of Sao Paulo at 1 site in Brazil.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 26 Oct 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Brazil. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Clinical Parameter (time frame: 2 years). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03039244, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Oct 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in